16/06/2020 (Agence Europe) – Germany will invest 300 million euros in the company CureVac to support the development of a vaccine against Covid-19, Federal Economics Minister Peter Altmaier announced on 15 June. This investment “aims to ensure that the company is not taken over by a foreign investor and that it does not leave the country”, says a letter from the German Ministry unveiled by the Financial Times. And this at a time when the company was planning an IPO on the Nasdaq in...